Related Experiment Video
Updated: Feb 10, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Clinically validated immune-related gene markers and molecular subtypes in acute myocardial infarction revealed by
Qingquan Zhang1, Mingyan Yu1, Peiran Xu1
1Department of Cardiology, The Second Affiliated Hospital of Nantong University, Nantong First People's Hospital, Nantong, Jiangsu, China.
Background:
Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide. Beyond ischemic injury, sterile inflammation and immune activation critically shape infarct expansion, healing, and adverse remodeling. However, immune-related genes (IRGs) that distinguish AMI from stable coronary artery disease (sCAD) and reflect patient heterogeneity remain incompletely characterized.
Methods:
Two microarray datasets (GSE59867 and GSE62646) were retrieved from database and integrated after batch correction. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were combined with CIBERSORT to identify differentially expressed immune-related genes (DEIRGs) and hub genes associated with immune infiltration. Consensus clustering was then applied to explore molecular subtypes of AMI. Finally, hub genes were preliminarily validated by RT-qPCR in a clinical cohort and in an independent public dataset (GSE60993).
Results:
A total of 155 differentially expressed genes (DEGs) and 27 DEIRGs were identified. WGCNA highlighted the MEblue module as most strongly associated with AMI, and intersection analysis yielded 13 overlapping DEIRGs. Protein-protein interaction analysis prioritized six hub genes (CSF3R, CD14, AQP9, S100A9, SLC11A1, and IL1RN), which were mainly correlated with neutrophil and monocyte fractions. Consensus clustering indicated three molecular subtypes with distinct hub-gene expression patterns. RT-qPCR confirmed significantly increased expression of AQP9, S100A9, and SLC11A1 in AMI compared with sCAD. External validation in GSE60993 supported the diagnostic potential of the identified genes.
Conclusions:
AQP9, S100A9, and SLC11A1 are promising immune-related biomarkers and may reflect heterogeneity in inflammatory responses among AMI patients. These findings provide mechanistic clues and candidate targets for future experimental and translational studies.
More Related Videos
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Reliability and Validity
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

